Novotech 的亚太地区和美国领导团队参加 BIO 2022
SAN DIEGO, CA, Jun 15, 2022 – (亚太商讯 via SEAPRWire.com) – Novotech 是亚太地区领先的生物技术临床研究机构，最近将其服务扩展到美国，将邀请来自亚太地区和美...
Novotech助力Endpoints ASCO 2022年专家组，加速中国肿瘤临床试验
SYDNEY, Jun 7, 2022 – (亚太商讯 via SEAPRWire.com) – Novotech是亚太地区领先的生物技术临床研究机构，近期入驻美国，助力Endpoints ASCO 2022年专家组...
Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China
SYDNEY, Jun 6, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, is sponsoring the Endpoints ASCO22 “Accelerating clinical development in China and the US”. Register here https://asco22.endpts.com/TUESDAY, JUNE 711:00am – 11:45am ET (1:00 – 1:45 local time)Novotech Booth at... » read more
Novotech 赞助 ASCO 中国峰会前中美早期肿瘤试验和监管策略专家组
SYDNEY, Jun 3, 2022 – (亚太商讯 via SEAPRWire.com) – Novotech 是亚太地区领先的生物技术专家 CRO，最近将其服务扩展到美国，在 2022 年 ASCO 前中国峰会...
Novotech 赞助 ASCO 中国峰会前夕：基于早期肿瘤学试验的 Go/No Go 决策
SYDNEY, May 12, 2022 – (亚太商讯 via SEAPRWire.com) – Novotech 是亚太地区领先的生物技术专家 CRO，最近将其 CRO 服务扩展到美国，很高兴赞助 2022 年 ...
Novotech Sponsors Pre-ASCO China Summit: Go/No Go Decisions Based on Early Phase Oncology Trials
SYDNEY, May 12, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its CRO services to the US, is pleased to sponsor the Pre-ASCO China Summit 2022 event titled: Go/No Go Decisions Based on Early Phase Oncology Trials (‘The Summit’). The Summit will feature insights... » read more
Novotech Acquires US CRO NCGS, Expands Global Expertise
Singapore & Charlotte, NC, May 5, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia-Pacific biotech specialist CRO, has acquired US CRO NCGS as part of its expansion program, and can now offer its biotech clients clinical services in the US to support later phase global studies. NCGS, established in 1984 in South... » read more